Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer

DALLAS, April 18, 2022 -- (Healthcare Sales & Marketing Network) -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal diseases, today announced Aaron Osborne, MBBS, was appointed Chief Medical Office... Biopharmaceuticals, Personnel Nanoscope Therapeutics, gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news